Podcasts

Episode 19 | Consider Every Trial as a TeleTrial

A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner to positively impact the future of trials in Australia.

Consider Every Trial as a TeleTrial

Episode Summary

A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner. New frameworks are increasing clinical trial participation and co ordination between trial and satellite centres is improving. Imaging, blood tests and examinations can be done at a local level, without extensive travel that was deemed necessary in the past. Barriers and facilitators and a unique insight into the patient benefits are discussed between Alexandra Golledge, Prof Sabe Sabesan and A/Prof Craig Underhill. Incentive funding and harmonising governance requirements for TeleTrials in Australia will help solve many of these issues and continue to transform the way trials are managed. The benefits for patients and their families are clear and positively impact the future of trials in Australia.

 

Resources:

 

Supported by Takeda

 

Disclaimer: The opinions, beliefs and viewpoints expressed by the various authors and participants contained in this message do not necessarily reflect the opinions, beliefs and viewpoints of TOGA or official policies of TOGA. Dosage & administration of any treatments mentioned during TOGA medical education may differ between Regions. Please refer to your local prescribing information for further details.

Show Hosts

This episode’s host are:

  • Alexandra Golledge, patient advocate, teletrials participant and lung cancer survivor
  • Prof Sabe Sabesan, Medical Oncologist, ICON Cancer Centre Townsville; Co-Chair, Australian Teletrial Program and initial teletrials pilot 2017-2020
  • A/Prof Craig Underhill, Medical Oncologist, Border Medical Oncology and Haematology Albury/Wodonga

Play Episode 19 | Consider Every Trial as a TeleTrial

More Podcasts

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
We dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining